Strongbridge Biopharma: Strongbridge Biopharma : Certain Litigation Relating to the Transaction (Form 8-K)

(marketscreener.com) Certain Litigation Relating to the Transaction As previously disclosed, on May 24, 2021, Strongbridge Biopharma plc entered into a Transaction Agreement with Xeris Pharmaceuticals, Inc. , Xeris Biopharma Holdings, Inc. and Wells MergerSub, Inc. , pursuant to which HoldCo will acquire Strongbridge by means of a scheme of...https://www.marketscreener.com/quote/stock/STRONGBRIDGE-BIOPHARMA-PL-24203396/news/Strongbridge-Biopharma-Certain-Litigation-Relating-to-the-Transaction-Form-8-K-36280950/?utm_medium=RSS&utm_content=20210830